Though the risk of losing hair appears to be small and likely reversible in many cases, people on GLP-1s and their doctors should be aware of the potential side effect, the researchers say
Read more: To view or add a comment, sign in Exciting news from DiaSorin
However, older women may need more conservative dose titration, more frequent monitoring, and careful attention to drug interactions with other medications
Provider care Medication if prescribed Treatment supplies Expedited shipping Compounded Semaglutide is not FDA-approved
The TRIUMPH-4 Phase 3 trial showed 28.7% average weight loss with retatrutide 12 mg at 68 weeks, compared to 14.9% to 17.4% with semaglutide 2.4 mg across STEP trials
Acute liver injury following turmeric use in Tuscany: an analysis of the Italian Phytovigilance database and systematic review of case reports